نتایج جستجو برای: angiotensin 1

تعداد نتایج: 2785304  

Journal: :Hypertension 2007
Shetal H Padia Brandon A Kemp Nancy L Howell Helmy M Siragy Marie-Claude Fournie-Zaluski Bernard P Roques Robert M Carey

The renal angiotensin angiotensin type 2 receptor has been shown to mediate natriuresis, and angiotensin III, not angiotensin II, may be the preferential angiotensin type 2 receptor activator of this response. Angiotensin III is metabolized to angiotensin IV by aminopeptidase N. The present study hypothesizes that inhibition of aminopeptidase N will augment natriuretic responses to intrarenal a...

Journal: :research in cardiovascular medicine 0
yan-min xu department of cardiology, tianjin medical university, tianjin, republic of china; department of cardiology, tianjin medical university. tianjin, republic of china. tel: +86-2288328339, fax: +86-2228261158 deepak sharma department of cardiology, tianjin medical university, tianjin, republic of china guang-ping li department of cardiology, tianjin medical university, tianjin, republic of china ya-nan zhao department of cardiology, tianjin medical university, tianjin, republic of china

materials and methods: 32 new zealand rabbits were randomly divided into three groups: control group, high-cholesterol group and losartan group. the level of weights, serum lipid levels and inflammatory factors, such as il-6 and hs c-reactive protein were detected before the losartan intervention and two months after the losartan intervention respectively. the content of angii was detected on l...

Journal: :Circulation research 1975
A L Blumberg J A Ackerly M J Peach

The effect of angiotensin on the action of tyramine was studied in isolated rabbit left atria paced by point and field stimulation to more clearly define the interaction of angiotensin with the sympathetic nervous system. Administration of angiotensin resulted in similar increases in contractility in both point- and field-stimulated atria. In point-stimulated preparations only the muscle is sti...

Journal: :Hypertension 2004
Duncan J Campbell Theodora Alexiou Hong D Xiao Sebastien Fuchs Michael J McKinley Pierre Corvol Kenneth E Bernstein

There is uncertainty about the contribution of angiotensin-converting enzyme (ACE) to angiotensin II formation, with recent studies suggesting that non-ACE enzymes may be the predominant pathway of angiotensin II formation in kidney, heart, and lung. To investigate the role of ACE in angiotensin II formation, we measured angiotensin I and II levels in blood, kidney, and heart of 2 mouse genetic...

Journal: :Hypertension 2013
Jorge F Giani Sebastien Fuchs Romer A Gonzalez-Villalobos

Journal: :Journal of the renin-angiotensin-aldosterone system : JRAAS 2005
Ion Haulica Walther Bild Dragomir N Serban

The concept of tissue renin-angiotensin systems (RAS) is now well established and it is now usual to think in terms of renal and tissue systems. At the same time it has emerged that angiotensin II (Ang II) is not the only biologically active peptide generated by the RAS. At least three others have been identified: the heptapeptide Ang III, the hexapeptide Ang IV and Ang 1-7. Specific receptors ...

Journal: :Molecular Pharmacology 2021

Angiotensin II (Ang II) is the most dominant effector component of renin-angiotensin system (RAS) that generally acts through binding to two main classes G protein–coupled receptors, namely Ang subtype 1 receptor (AT1R) and angiotensin 2 (AT2R). Despite some controversial reports, activation AT2R antagonizes effects on AT1R. Studying signaling, function, its specific ligands in cell culture or ...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2005
Yoshihiro Taniyama Hirofumi Hitomi Anand Shah R Wayne Alexander Kathy K Griendling

OBJECTIVE Angiotensin II has been implicated in the pathogenesis of the vascular complications of insulin resistance. Recently, serine phosphorylation and degradation of insulin receptor substrate-1 (IRS-1) were shown to inhibit Akt activation and reduce glucose uptake. Therefore, we examined the effects of chronic angiotensin II treatment on IRS-1 phosphorylation and protein expression in vasc...

Journal: :Molecular pharmacology 2015
Takanobu Takezako Hamiyet Unal Sadashiva S Karnik Koichi Node

Ligand-independent signaling by the angiotensin II type 1 receptor (AT1R) can be activated in clinical settings by mechanical stretch and autoantibodies as well as receptor mutations. Transition of the AT1R to the activated state is known to lower inverse agonistic efficacy of clinically used AT1R blockers (ARBs). The structure-function basis for reduced efficacy of inverse agonists is a fundam...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید